Advertisement
Canada markets open in 7 hours 21 minutes

  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CAD/USD

    0.7306
    -0.0015 (-0.20%)
     

  • CRUDE OIL

    78.69
    +0.21 (+0.27%)
     

  • Bitcoin CAD

    87,020.24
    -807.77 (-0.92%)
     

  • CMC Crypto 200

    1,366.40
    +1.28 (+0.09%)
     

  • GOLD FUTURES

    2,330.00
    -1.20 (-0.05%)
     

  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • NASDAQ futures

    18,179.00
    -16.50 (-0.09%)
     

  • VOLATILITY

    13.49
    0.00 (0.00%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,765.17
    +529.10 (+1.38%)
     

  • CAD/EUR

    0.6790
    -0.0002 (-0.03%)
     

UPDATE 1-Moderna COVID-19 vaccine plant in France gets approval

Reuters
·1 min read

(Adds details of approval, background)

June 11 (Reuters) - The European Medicines Agency (EMA) on Friday approved a new manufacturing site in France for the production of Moderna Inc's COVID-19 vaccine.

The site at Monts will be operated by Recipharm and produce the finished product, the EMA's committee for human medicines (CHMP) said. (https://bit.ly/3pQ6YJt)

Earlier this month, the CHMP approved two new sites in the United States to produce both active substance and the finished product for Moderna's vaccine.

It expects these moves to allow production of an additional one million to two million vials of ready-to-use vaccine for the European Union market every month.

Moderna already has a deal with Thermo Fisher Scientific's commercial manufacturing site in Greenville, North Carolina that will support production of "hundreds of millions" of doses. (Reporting by Vishwadha Chander in Bengaluru; Editing by Shounak Dasgupta and Subhranshu Sahu)